Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
9,754 studies for “Japan”
Sponsor: Pfizer
Moderate to Severe Chronic Obstructive Pulmonary Disease
United States, Argentina, Canada, China, India +3 more
Sponsor: Immunovant Sciences GmbH
Graves' Disease
United States, Australia, Brazil, Bulgaria, Chile +12 more
Sponsor: GlaxoSmithKline
Non-alcoholic Fatty Liver Disease
United States, Australia, Canada, Hong Kong, Japan +4 more
Sponsor: Janssen Research & Development, LLC
Myasthenia Gravis
United States, Australia, Belgium, Canada, China +12 more
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney DiseaseActive Not Recruiting
Sponsor: Boehringer Ingelheim
Chronic Kidney Disease
United States, Argentina, Australia, Belgium, Brazil +19 more
- Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung CancerActive Not Recruiting
Sponsor: AstraZeneca
Advanced or Metastatic NSCLC
United States, Belgium, Italy, Japan, Poland +3 more
- Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus ErythematosusActive Not Recruiting
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
United States, Argentina, Bulgaria, Chile, Colombia +10 more
Sponsor: Merck Sharp & Dohme LLC
Advanced Solid Tumors · Malignant Neoplasm
United States, Chile, China, France, Israel +7 more
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Multiple System Atrophy
United States, France, Germany, Israel, Italy +2 more
Sponsor: China-Japan Friendship Hospital
VAS Score · Quadriceps Strength
China
- An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusEnrolling By Invitation
Sponsor: Biogen
Systemic Lupus Erythematosus (SLE)
United States, Argentina, Belgium, Brazil, Bulgaria +22 more
- Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Head and Neck Neoplasms
United States, Argentina, Australia, Austria, Belgium +19 more
Sponsor: Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis
United States, Argentina, Australia, Austria, Belgium +23 more
- Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Malignant Neoplasm
United States, Israel, Japan, Switzerland
Sponsor: Eli Lilly and Company
Metastatic Solid Tumor · Recurrent Solid Tumor · Advanced Solid Tumor · Urinary Bladder Neoplasm
United States, Australia, China, France, Japan +3 more
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Belgium, Brazil +26 more
- Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Von Hippel-Lindau Disease · Malignant Neoplasms
United States, Australia, Belgium, Brazil, Canada +17 more
Sponsor: Avidity Biosciences, Inc.
Facioscapulohumeral Muscular Dystrophy · FSHD · FSHD - Facioscapulohumeral Muscular Dystrophy · FSHD1
United States, Canada, Denmark, France, Germany +5 more
Sponsor: AbbVie
Small Cell Lung Cancer
United States, Belgium, China, Germany, Israel +7 more
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms · Triple Negative Breast Neoplasms · HR Low-Positive/HER2-Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +34 more
- Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesActive Not Recruiting
Sponsor: AbbVie
Hematologic Cancer
United States, Canada, France, Germany, Israel +4 more
- A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus ErythematosusActive Not Recruiting
Sponsor: Biogen
Subacute Cutaneous Lupus Erythematosus · Chronic Cutaneous Lupus Erythematosus
United States, Argentina, Belgium, Brazil, Bulgaria +25 more
Sponsor: Daiichi Sankyo
Urothelial Cancer · Bladder Cancer
United States, Austria, China, France, Germany +2 more
Sponsor: AbbVie
Solid Tumors Harboring MET Amplification
United States, Israel, Japan, South Korea, Spain
- A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib StudiesRecruiting
Sponsor: Mirati Therapeutics Inc.
Solid Tumors
United States, Australia, Belgium, Canada, China +15 more
9,754 studies found